Posted on December 2, 202412/2/24
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer
Posted on November 27, 202411/27/24
From Challenges to Solutions: Breaking Barriers to Revolutionize Patient Services
Posted on November 12, 202411/12/24
Finding the Human Element Amid the Algorithms
Posted on September 27, 20249/27/24
Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024
Posted on September 5, 20249/5/24
The Promise of a Direct-to-Patient Model – Breaking Down What’s Really Needed for Better Patient Access
Posted on September 3, 20249/3/24
The Future of Global Commercialization: Unified, Data-Driven and Patient-Centric
Posted on August 13, 20248/13/24
IDN Trends, Insights and Strategies Every Manufacturer Should Know
Posted on August 5, 20248/5/24
Understanding IDNs and What They Mean to the Pharmaceutical Industry–Q&A with Greg Skalicky
Posted on July 22, 20247/22/24
PDURS Explained: The FDA’s New Framework for Adding Software to Drug Labels
Posted on July 17, 20247/17/24